| 000 | 01723 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516172324.0 | ||
| 264 | 0 | _c20140416 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1879-4076 | ||
| 024 | 7 |
_a10.1016/j.jgo.2013.04.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDerbel Miled, Olfa | |
| 245 | 0 | 0 |
_aSorafenib and sunitinib for elderly patients with renal cell carcinoma. _h[electronic resource] |
| 260 |
_bJournal of geriatric oncology _cJul 2013 |
||
| 300 |
_a255-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAsthenia _xchemically induced |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDrug Eruptions _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aSunitinib |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDionne, Christine | |
| 700 | 1 | _aTerret, Catherine | |
| 700 | 1 | _aSegura-Ferlay, Céline | |
| 700 | 1 | _aFlechon, Aude | |
| 700 | 1 | _aNeidhart, Eve-Marie | |
| 700 | 1 | _aNegrier, Sylvie | |
| 700 | 1 | _aDroz, Jean-Pierre | |
| 773 | 0 |
_tJournal of geriatric oncology _gvol. 4 _gno. 3 _gp. 255-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jgo.2013.04.004 _zAvailable from publisher's website |
| 999 |
_c23121136 _d23121136 |
||